kras mutation and glutathion The roles of in cancer metabolism, tumor microenvironment clinical therapy | Molecular Cancer KRAS G12D: The Next Frontier
KRAS G12D: The Next Frontier in Cancer Therapy MedChemExpress Uncovering new therapeutic targets for a common KRAS mutation behind cancer KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy Targeting KRAS mutant stomach colorectal tumors by disrupting the ERK2 p53 complex ScienceDirect JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma
Pay in 4 interest-free payments of $6.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




